$NDAQ

Smith Bryan Everard sold $240K of NDAQ

Smith Bryan Everard (EVP, CPO) sold 3,000 shares of NASDAQ, INC. (NDAQ) at $80.00 ($0.24M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Bryan Everard
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NDAQ
Neutral
high confidence
Mentioned
$NDAQ
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NDAQNeutralLow
01

Why it matters

The only new fact is the specific sale details: 3,000 shares sold at $80 on 2026-07-01, with holdings after the transaction of 69,203 shares, under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but there is no fundamental catalyst or guidance change in the text.

03

What to watch

The article provides no information on whether the sale was part of a larger scheduled program, whether there were concurrent purchases, or whether the insider’s remaining holdings changed materially beyond the post-transaction figure.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-02 after the sale on 2026-07-01.

Background

The article is a SEC Form 4 insider transaction disclosure for NASDAQ, Inc. (NDAQ).

Company-level read

Ticker impact

$NDAQNeutralHigh confidence
Context

NDAQ disclosed an insider Form 4 showing EVP/CPO Smith Bryan Everard sold 3,000 shares at $80 on 2026-07-01 under a 10b5-1 plan.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and short-lived.

Evidence & confidence

The filing is an open-market sale by an insider under a pre-arranged 10b5-1 plan, with no accompanying operational, financial, or regulatory change described.

Market effects

Minimal; insider sales under 10b5-1 do not typically reset sector expectations for exchanges.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can be interpreted by some traders as a mild confidence signal, especially if it coincides with other negative catalysts not mentioned here.

Key entities

  • NASDAQ, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Smith Bryan Everard

    EVP, CPO who executed an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NDAQHighAI 8/10

Nasdaq Bought an AI Due-Diligence Platform as ICE Built Private-Credit Intelligence. Which Data Moat Is Deeper?

Nasdaq completed its acquisition of Dasseti, an AI-assisted due-diligence platform covering 17,000 managers and $34T in assets. Intercontinental Exchange (ICE) is building private-credit data intelligence with Apollo. Nasdaq aims to deepen its network, while ICE focuses on security-level data. Both companies face integration and monetization risks. Nasdaq's short interest is 1.66% of float. Investors should watch renewal rates and revenue contributions.

$NDAQMedAI 9/10

Nasdaq Completes Acquisition of Dasseti

Nasdaq (NDAQ) completed its acquisition of Dasseti, an AI-powered due diligence platform. Dasseti's capabilities will be integrated into Nasdaq eVestment, enhancing manager research and monitoring. The deal was first announced in July 2026. Financial terms were not disclosed. Dasseti covers 17,000 asset managers and $34 trillion in assets under management.

$NDAQMedAI 8/10

Nasdaq, Inc.: Nasdaq Completes Acquisition of Dasseti, Deepening Nasdaq eVestment's AI and Private Markets Capabilities

Nasdaq (NDAQ) completed its acquisition of Dasseti, an AI-driven due diligence platform, for undisclosed terms. Dasseti will be integrated into Nasdaq eVestment, enhancing its manager research and monitoring capabilities. The deal expands Nasdaq eVestment's coverage to 16,000 private market managers and 95,000 funds, aiming to improve efficiency for institutional investors.

$MSLow

Y'all Street is booming: What financial giants like Morgan Stanley and Goldman Sachs are building in Texas

Morgan Stanley, Goldman Sachs, Bank of America, JPMorgan Chase, NYSE, Charles Schwab, Nasdaq, and Citi are expanding their operations in Texas. Morgan Stanley plans a $587M building in Dallas by 2031, while Goldman Sachs is investing $500M in a new Dallas campus. Bank of America is moving to a new Dallas tower, and JPMorgan Chase has doubled its Plano campus workforce. NYSE is relocating its Chicago outpost to Dallas. Charles Schwab, Nasdaq, and Citi also have significant Texas operations. Wise

$COINLow

CFTC Innovation Advisory Committee Debuts With Coinbase, CME, and Kalshi Chiefs at the Table

The CFTC's new Innovation Advisory Committee, chaired by Walt Lukken, held its first meeting with 40+ members, including CEOs from Coinbase, CME, Kalshi, and other crypto and traditional market firms. The agenda covered crypto regulation, AI in finance, and prediction markets. The CFTC has a track record in crypto regulation, including approving bitcoin perpetual futures contracts. The meeting follows a White House event where President Trump discussed crypto regulation with industry executives.